⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockNetherlandsBrussels

ARGX.BR

argenx SE

Healthcare · Biotechnology

865.20EUR

-0.6000 (-0.07%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY410.7M1.2B2.2B4.2B6.2B7.7B
Q1————1.3B—
Q2———948.0M1.5B—
Q3———1.1B1.6B—
Q4———1.3B1.8B—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY-13.05-5.1612.7819.5728.4235.93
Q1———2.585.52—
Q2——————
Q3————7.97—
Q4——

Fiscal period: Reported, Estimated. Reported figures: Yahoo Finance (limited history). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

—
8.07
8.31
—